多甲氧基黄酮类化合物紫花牡荆素是中国传统中草药蔓荆子的主要活性成分之一，具有抗炎、抗肿瘤等功效。本文对紫花牡荆素的来源、构效关系、抗肿瘤作用及其作用机制等的研究进展进行总结，以期为紫花牡荆素抗肿瘤作用机制的深入研究和临床开发应用提供参考。

Casticin, a ploymethoxyflavanoid casticin, possesses anti-inflammatory and anti-tumor properties. It is one of the major active components from Chinese herbal simpleleaf shrub chastetree fruit. This review summarized the research progress in casticin, in which the source, the relation between structure and activity, the anti-tumor effects and the underlying mechanisms were included. The main purpose of this review is to provide information for the ani-tumor effect of casticin and the potential clinical application.

湖南省卫生厅科研基金

［1］Falk AJ, Smolenski SJ, Bauer L, et al. Isolation and identification of three new flavones from Achillea millefolium L［J］. J Pharm Sci, 1975, 64 (11): 1838-1842.
［2］Zeng X, Fang Z, Wu Y, et al. Studies on the chemical constituents of the fruits of Vitex trifolia L.［J］. Chin J  Chin Mat Med, 1996, 21 (3): 167-168, 1691.
［3］Alam G, Wahyuono S, Ganjar IG, et al. Tracheospasmolytic activity of Viteosin-A and Vitexicarpin isolated from Vitex trifolia［J］. Planta Med, 2002, 68 (11): 1047-1049.
［4］You KM, Son KH, Chang HW, et al. Vitexicarpin, a flavonoid from the fruits of Vitex rotundifolia, inhibits mouse lymphocyte proliferation and growth of cell lines in vitro［J］. Planta Med, 1998, 64 (6): 546-550.
［5］Ko WG, Kang TH, Lee SJ, et al. Polymethoxyflavonoids from Vitex rotundifolia inhibit proliferation by inducing apoptosis in human myeloid leukemia cells［J］. Food Chem Toxicol, 2000, 38 (10): 861-865.
［6］Yoshioka T, Inokuchi T, Fujioka S,et al. Phenolic compounds and flavonoids as plant growth regulators from fruit and leaf of Vitex rotundifolia［J］. Z Naturforsch C, 2004, 59 (7-8): 509-514.
［7］Choudhary MI, Jalil S, Nawaz SA, et al. Antiinflammatory and lipoxygenase inhibitory compounds from Vitex agnus-castus［J］. Phytother Res, 2009, 23(9):1336-1339.
［8］Mesaik MA, Murad S, Khan KM, et al. Isolation and immunomodulatory properties of a flavonoid, casticin from Vitex agnus-castus［J］. Phytother Res, 2009. ［Epub ahead of print］
［9］Kobayakawa J, Sato-Nishimori F, Moriyasu M, et al. G2-M arrest and antimitotic activity mediated by casticin, a flavonoid isolated from Viticis Fructus (Vitex rotundifolia Linne fil.)［J］. Cancer Lett, 2004, 208 (1): 59-64.
［10］Orabi KY, Mossa JS, Muhammed I, et al. New eudesmane sesquiterpenes from Plectranthus cylindraceus［J］. J Nat Prod, 2000, 63 (12): 1665-1668.
［11］Han X, Ma X, Zhang T,et al. Isolation of high-purity casticin from Artemisia annua L. by high-speed counter-current chromatography［J］. J Chromatogr A, 2007, 1151 (1-2): 180-182.
［12］Diaz F, Chavez D, Lee D, et al. Cytotoxic flavone analogues of Vitexicarpin, a constituent of the leaves of Vitex negundo［J］. J Nat Prod, 2003, 66 (6): 865-7.86
［13］Li WX, Cui CB, Cai B,et al. Flavonoids from Vitex trifolia L. inhibit cell cycle progression at G2/M phase and induce apoptosis in mammalian cancer cells［J］. J Asian Nat Prod Res, 2005, 7 (4): 615-626.
［14］Beutler JA, Hamel E, Vlietinck AJ, et al. Structure-activity requirements for flavone cytotoxicity and binding to tubulin［J］. J Med Chem, 1998, 41 (13): 2333-2338.
［15］Kawaii S, Tomono Y, Katase E, et al. Antiproliferative activity of flavonoids on several cancer cell lines［J］. Biosci Biotechnol Biochem, 1999, 63 (5): 896-899.
［16］Wang HY, Cai B, Cui CB, et al. Vitexicarpin, a flavonoid from Vitex trifolia L., induces apoptosis in K562 cells via mitochondria-controlled apoptotic pathway［J］. Acta Pharmaceutica Sinica, 2005, 40 (1): 27-31.
［17］Shen JK, Du HP, Yang M, et al. Casticin induces leukemic cell death through apoptosis and mitotic catastrophe［J］. Ann Hematol, 2009, 88(8):743-752.
［18］Haidara K, Zamir L, Shi QW, et al. The flavonoid casticin has multiple mechanisms of tumor cytotoxicity action［J］. Cancer Lett, 2006, 242 (2): 180-190.
［19］Chen LL, Gansbacher B, Gilboa E, et al. Retroviral gene transfer of epidermal growth factor receptor into HL60 cells results in a partial block of retinoic acid-induced granulocytic differentiation［J］. Cell Growth Differ, 1993, 4 (9): 769-776.
［20］Longley DB, Johnston PG. Molecular mechanisms of drug resistance［J］. J Pathol, 2005, 205 (2): 275-292.